Canada markets closed

BioSyent Inc. (RX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
9.15-0.04 (-0.44%)
At close: 03:59PM EDT
Full screen
Previous Close9.19
Open9.18
Bid9.13 x 0
Ask9.15 x 0
Day's Range9.00 - 9.19
52 Week Range7.03 - 9.26
Volume11,929
Avg. Volume7,595
Market Cap106.005M
Beta (5Y Monthly)0.93
PE Ratio (TTM)17.26
EPS (TTM)0.53
Earnings DateAug 20, 2024 - Aug 26, 2024
Forward Dividend & Yield0.18 (2.12%)
Ex-Dividend DateFeb 28, 2024
1y Target Est9.65
  • Simply Wall St.

    BioSyent (CVE:RX) Has Affirmed Its Dividend Of CA$0.045

    The board of BioSyent Inc. ( CVE:RX ) has announced that it will pay a dividend of CA$0.045 per share on the 15th of...

  • GlobeNewswire

    BioSyent Releases Financial Results for Q1 2024

    MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: (CAD)Q1 2024% Change vs.Q1 2023Trailing Twelve Months(TTM) March 31, 2024% Change vs.TTMMarch 31, 2023Canadian Pharma Sales7,546,14418%30,689,34916%International Pharma Sales-0%1,047,747789%Total Company Sales7,733,63619%32,841,24420%EBITDA12,204,19345%8,614,03728%Net Income After Taxes (NIA

  • GlobeNewswire

    BioSyent Declares Second Quarter 2024 Dividend

    MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 2024, to shareholders of record at the close of business on May 31, 2024. This second quarter 2024 dividend compares with the first quarter 2024 dividend of $0.045 per common share. This dividend qualifies as an 'eligible dividend' f